Dr. Reddy's Faces ₹2,395 Crore Tax Reassessment

  Published 10 months ago

Dr. Reddy's Laboratories is facing a ₹2,395.82 crore tax reassessment notice for AY 2020-21, following its merger with Dr. Reddy's Holding Limited. The company disputes the claim and expects minimal impact.

  • Tax notice issued under Section 148A.
  • Merger approved by NCLT in 2022.
  • Promoters to indemnify against liabilities.

You might like these

Godrej MSR City Drives Real Estate Growth in Bengaluru

HLE Glascoat Acquires Omeras, Expands Tank Market

Western Carriers India Bags 3-Year Jindal Stainless Logistics Contract

PNB Q2 Profit Up 14% on Retail Growth

SEBI & NSE Work to Clear IPO Issues

Paytm Soars 143% on Q1 Turnaround

TCS Layoffs Signal AI Disruption Ahead

News that matters the most ⚡